Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000577:Amides / Q000494:pharmacology*; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001168:Arthritis / Q000188:drug therapy; D002351:Carrageenan / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006099:Granuloma / Q000188:drug therapy; D006168:Guinea Pigs; D006207:Half-Life; D000882:Haplorhini; D006801:Humans; D007700:Kinetics; D008251:Macaca; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013843:Thiazines / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology; D013997:Time Factors; D014466:Ultraviolet Rays
D000276:Adjuvants, Immunologic; D000577:Amides; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D013843:Thiazines; D013844:Thiazoles; D002351:Carrageenan